Suzanne Dowson
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
Papers in
-
- CRISPR and Genetic Engineering 5
- Viral Infectious Diseases and Gene Expression in Insects 3
- Cell death mechanisms and regulation 1
- Epigenetics and DNA Methylation 1
- Oncology 5
- CAR-T cell therapy research 4
- Co-authors
- Iain A. McNeish (11 shared papers)Malcolm Farquharson (5 shared papers)Darren Ennis (6 shared papers)Josephine Walton (5 shared papers)Karen Blyth (6 shared papers)Elaine Leung (5 shared papers)David Stevenson (4 shared papers)Susan Mason (5 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Molecular Cancer Research (1 paper)Molecular Oncology (1 paper)Cell Death and Disease (1 paper)Scientific Reports (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
Suzanne Dowson
10 papers receiving 348 citations
Peers
Comparison fields: 5 of 47
- Reproductive Medicine 77
- Oncology 177
- Immunology 100
- Cancer Research 59
- Genetics 94
Countries citing papers authored by Suzanne Dowson
This map shows the geographic impact of Suzanne Dowson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Dowson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Dowson more than expected).
Fields of papers citing papers by Suzanne Dowson
This network shows the impact of papers produced by Suzanne Dowson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Dowson. The network helps show where Suzanne Dowson may publish in the future.
Co-authors
The 25 scholars most cited alongside Suzanne Dowson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 150 | |
| 2 | 2017 | 66 | |
| 3 | 2020 | 35 | |
| 4 | 2014 | 30 | |
| 5 | 2017 | 29 | |
| 6 | 2017 | 18 | |
| 7 | 2015 | 16 | |
| 8 | CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity | 2017 | 2 |
| 9 | 2018 | 1 | |
| 10 | 2016 | 1 | |
| 11 | 2019 | 0 |
About Suzanne Dowson
Suzanne Dowson is a scholar working on Molecular Biology, Oncology, Genetics, Reproductive Medicine and Cancer Research, having authored 11 papers that have together received 348 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (5 papers), Virus-based gene therapy research (5 papers), CAR-T cell therapy research (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Cancer-related molecular mechanisms research (2 papers), Cell death mechanisms and regulation (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Reproductive Medicine (77 citations), Oncology (177 citations), Immunology (100 citations), Cancer Research (59 citations) and Genetics (94 citations). Suzanne Dowson has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Iain A. McNeish, Malcolm Farquharson, Darren Ennis, Josephine Walton, Karen Blyth, Elaine Leung, David Stevenson, Susan Mason, Laura A. Tookman and Michelle Lockley. Their work appears in journals such as Clinical Cancer Research, Molecular Cancer Research, Molecular Oncology, Cell Death and Disease and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.